The risk of lower gastrointestinal bleeding in low ‐dose aspirin users
ConclusionsThe risk of LGIB was higher in low‐dose aspirin users than in aspirin nonusers in this nationwide cohort. Low‐dose aspirin, NSAIDs, steroids, SSRIs, PPIs and H2RAs were independent risk factors for LGIB.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: W. ‐C. Chen, K.‐H. Lin, Y.‐T. Huang, T.‐J. Tsai, W.‐C. Sun, S.‐K. Chuah, D.‐C. Wu, P.‐I. Hsu Tags: Original Article Source Type: research
More News: Aspirin | Bleeding | Calcium | Chronic Kidney Disease | Chronic Obstructive Pulmonary | Cirrhosis | Clopidogrel | Coumadin | Databases & Libraries | Diabetes | Diabetic Ulcers | Drugs & Pharmacology | Endocrinology | Gastroenterology | Health Insurance | Hypertension | Insurance | Ischemic Stroke | Liver | Peptic Ulcer | Plavix | Proton Pump Inhibitors PPIs | Stroke | Urology & Nephrology | Warfarin